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Abstract
Introduction: Postmenopausal endometriosis is a rare form of a common disease, since the absence of estrogenic
hormone production should halt disease progression.
Case presentation: We present the case of a 54-year-old Italian Caucasian woman in surgical menopause with a
history of ovarian endometriosis, who underwent voluntary hormone replacement therapy for seven years. She
developed postrenal renal failure due to bilateral compression of the pelvic ureteral tract caused by two large,
deeply infiltrating endometriotic nodules with no pelvic pain. She underwent operative laparoscopy with
adhesiolysis of enteroenteric adhesions and excision of the endometriotic nodules encompassing the juxtavesical
tract of the ureters, without obtaining improvement of renal failure.
Conclusion: Postmenopausal endometriosis can manifest itself in an unpredictable and potentially very serious
manner. It is therefore important to carefully evaluate the risks and benefits of administering hormone replacement
therapy to patients with previous endometriosis.
Introduction
Postmenopausal endometriosis is a rare form of a com-
mon disease, given that the absence of estrogenic hor-
mone production should halt disease progression [1].
Oxholm et al [2] reported that two to five percent of
endometriosis is diagnosed after menopause. It has been
reported that endometriosis may develop essentially in
women undergoing hormone replacement therapy [2]
with some exceptions [3], indicating the possibility that
in some cases endometriosis may be completely inde-
pendent of gonadic estrogens. Whether postmenopausal
endometriosis is due to exogenous estrogens or presum-
ably independent of gonadic estrogens, the silent growth
of the disease can result in potentially serious and
unpredictable complications. For example, it may grow
without the typical symptoms such as catamenial pain
and may involve the ureters [4,5] or bowel [6], produ-
cing complications such as renal failure or intestinal
obstruction. The following case explains the onset of
postmenopausal endometriosis with renal failure.
Case presentation
A 54-year-old Italian Caucasian woman, weighing 71 kg
and with a height of 160 cm, was admitted to our facil-
ity in order to have a laparoscopic removal of two
nodules compressing both ureters. She had received
diagnosis of endometriosis laparoscopically, when she
was 43. At 44 years of age, she underwent a total
laparotomic hysterectomy with bilateral adnexectomy
for metrorrhagia from uterine fibromatosis. During the
operation and after pathological examination, no sign of
endometriosis was found. Subsequently, she underwent
voluntary hormone replacement therapy (estrogen-based
only) for seven years with good general health until the
detection, during the eighth year of menopause, of renal
failure due to bilateral hydronephrosis (detected via
MRI). The bilateral hydronephrosis was induced by
extrinsic compression of both ureters (at supravesical
fossa) by nodules compatible with deeply infiltrating
endometriosis. S-Ca 125 appeared within the norm (nor-
mal values are considered below 31 microU/ml) and no
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months after instrumental diagnosis and following sub-
sequent ureteral stenting, her creatinine value was 1.71
mg/dl (range 0.66 to 1.09 mg/dl), with blood urea nitro-
gen at 57 mg/dl (range 17 to 43 mg/dl). S-Ca 125 again
appeared to be within the normal range (below 31
microU/ml). She then underwent operative laparoscopy
with adhesiolysis of entero-enteric adhesions and exci-
sion of endometriotic nodules encompassing the juxta-
vesical tract of the ureters: on the right extending to the
external iliac artery and obturator foramen and on the
left, to the rectum. Pathological examination of the
excised nodules confirmed the instrumental and laparo-
scopic diagnosis of postmenopausal endometriosis.
Post-operative recovery was complicated by broncho-
pneumonia. After hospital discharge, creatinine value
was 1.56 mg/dl (range 0.66 to 1.09 mg/dl) with thinning
of the right renal cortex which suggested mild renal fail-
ure. Following removal of the ureteral stents three
months after surgery, the patient appeared to be in good
health despite the mild renal failure.
Discussion
For more than 10 years it has been acknowledged [7,8]
that endometriosis can express aromatase activity, parti-
cularly during tissue inflammation. In a recent review,
Attar and Bulun [9] illustrate how endometriosis can
express various enzymes from the biosynthetic pathway
of steroid hormones: estrogen production is caused by
aromatase activity during inflammatory episodes; in
addition, estrogen production can increase inflammation
of endometriotic tissue. During menopause it is plausi-
ble that endometriosis can grow independently of gona-
dic estrogens due to the renewed synthesis of estrogens
in the endometriotic nodule. Therefore, the effect of
estrogens may be variable overall, because inflammation
affects estrogen production in the nodule. In addition,
Rosa-e-Silva et al [3] proposed that obesity may have a
particular role in the growth of post-menopausal endo-
metriosis due to estrogen production by fatty tissue.
Oxholm et al [2] have recently reviewed cases of post-
menopausal endometriosis, pointing out that the major-
ity of postmenopausal endometriosis is detected in
patients undergoing hormone replacement therapy, par-
ticularly when only estrogen-based. In addition, the
onset of endometriosis during menopause appears to be
more probable following physiological menopause, sug-
gesting that the ovaries may have a certain role in the
disease even in the post-menopausal phase. The authors
[2] conclude that it is debatable overall whether hor-
mone replacement therapy can favor the growth of
endometriosis, implying, however, that this is possible in
some cases and that endometriosis should be taken into
consideration in menopausal patients presenting the
pain symptoms typical of the disease.
Conclusion
Even in fertile patients, endometriosis shows varying
biological behavior, with variable clinical symptoms and
outcomes in relation to hormonal status. However, it is
very difficult for a clinician to ascertain silent endome-
triosis post-menopause, when estrogen production is
lacking. In light of this case and of the varying biological
behavior of endometriosis, clinicians must certainly keep
in mind that postmenopausal endometriosis can appear
in an atypical manner and could go undetected, leading
to serious complications. This event may occur particu-
larly in patients with a type of hormonal trigger that
could aggravate inflammatory stress. Therefore, we
recommend a careful evaluation of whether or not to
prescribe hormone replacement therapy to patients in
menopause with previously ascertained endometriosis.
Patient perspective
The patient was not happy about her experience and
considers endometriosis a painful disease that she had
hoped would be cured with her hysterectomy with
adnexectomy. She hopes that the description of her
experience will be helpful in preventing and treating the
troubles that such a disease can provoke.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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